查找临床试验

已按「肺动脉高压」检索,对应国际通用词 pulmonary arterial hypertension

试验不在中国怎么办?

共找到 60 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 23:03,每 5 分钟自动同步
正在招募早期 I 期中国有中心NCT07662655

Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study

China

年龄 18 Years – 80 Years

Xiamen Cardiovascular Hospital, Xiamen University

正在招募II 期中国有中心NCT06721286

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

China

年龄 18 Years – 不限

Tianjin Medical University Cancer Institute and Hospital

正在招募不适用中国有中心NCT05311072

Change-a Multi-center Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Database in China

China

年龄 14 Years – 不限

China-Japan Friendship Hospital

正在招募II 期中国有中心NCT06925516

A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC

China

年龄 18 Years – 75 Years

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

正在招募不适用中国有中心NCT05595200

Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension

China

年龄 18 Years – 不限

Chinese Pulmonary Vascular Disease Research Group

正在招募不适用中国有中心NCT06832163

Close Loop Smart Weaning for INO With PPHN

China

年龄 不限 – 不限

Children's Hospital of Fudan University

正在招募不适用中国有中心NCT06135909

CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy

China

年龄 18 Years – 85 Years

Chinese Pulmonary Vascular Disease Research Group

正在招募III 期中国有中心NCT06922240

Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)

China

年龄 18 Years – 不限

Suqiao Yang

正在招募III 期NCT07179380

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

United States、Argentina、Australia、Austria、Belgium 等 12 国

年龄 18 Years – 不限

Insmed Incorporated

正在招募I 期中国有中心NCT06554301

A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension

China

年龄 18 Years – 不限

China National Center for Cardiovascular Diseases

正在招募不适用中国有中心NCT07852403

PAH-SDB: Sleep-Disordered Breathing and Outcomes in Pulmonary Arterial Hypertension

China

年龄 18 Years – 不限

Chinese Pulmonary Vascular Disease Research Group

正在招募不适用中国有中心NCT06476470

Taiwan Interstitial Lung Disease Multi-center Investigation and Registry

Taiwan

年龄 18 Years – 不限

Taichung Veterans General Hospital